Skip to main content
Erschienen in: Journal of Neurology 11/2018

27.08.2018 | Original Communication

Risk factors of suicidal ideation in Huntington’s disease: literature review and data from Enroll-HD

Erschienen in: Journal of Neurology | Ausgabe 11/2018

Einloggen, um Zugang zu erhalten

Abstract

Suicide is a leading cause of death in Huntington’s disease (HD), following pneumonia. Up to one-fifth of individuals with HD report suicidal ideation. Identifying the risk factors of suicidal ideation in this clinical population is thus pivotal. Here, we review the literature on prevalence rates and risk factors of suicidal ideation in premanifest and manifest patients and re-evaluate them using the largest currently existing clinical dataset from the ongoing observational study “Enroll-HD” (N = 5709). Large scale studies yielded important insights regarding suicidal ideation in HD. However, estimated prevalence rates vary among studies and risk factors are still poorly understood. According to the Enroll-HD data, pre- and manifest disease stages are associated with current (5.8–10%) and a history of suicidal ideation (18.6–30.9%). Throughout the course of HD, a history of suicidal ideation and the presence of depressive symptoms were strongly associated with current suicidal ideation. However, while for premanifest individuals, socio-demographics and activities of daily living appear to be important, in manifest patients, suicidal ideation is more closely linked to anxiety, irritability, psychosis, and apathy. These results highlight the importance of treating depressive symptoms in patients with HD and addressing potential suicidal ideation during clinical monitoring. The relevance of risk factors may differ among premanifest and manifest patients.
Literatur
2.
Zurück zum Zitat Nock MK, Borges G, Bromet EJ et al (2008) Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry 192(2):98–105CrossRef Nock MK, Borges G, Bromet EJ et al (2008) Cross-national prevalence and risk factors for suicidal ideation, plans and attempts. Br J Psychiatry 192(2):98–105CrossRef
3.
Zurück zum Zitat Bolton JM, Gunnell D, Turecki G (2015) Suicide risk assessment and intervention in people with mental illness. BMJ 351:h4978-hCrossRef Bolton JM, Gunnell D, Turecki G (2015) Suicide risk assessment and intervention in people with mental illness. BMJ 351:h4978-hCrossRef
4.
Zurück zum Zitat Qin P, Nordentoft M, Hoyer EH, Agerbo E, Laursen TM, Mortensen PB (2006) Trends in suicide risk associated with hospitalized psychiatric illness: a case-control study based on Danish longitudinal registers. J Clin Psychiatry 67(12):1936–1941CrossRef Qin P, Nordentoft M, Hoyer EH, Agerbo E, Laursen TM, Mortensen PB (2006) Trends in suicide risk associated with hospitalized psychiatric illness: a case-control study based on Danish longitudinal registers. J Clin Psychiatry 67(12):1936–1941CrossRef
5.
Zurück zum Zitat Hesdorffer DC (2016) Comorbidity between neurological illness and psychiatric disorders. CNS spectrums 21(3):230–238CrossRef Hesdorffer DC (2016) Comorbidity between neurological illness and psychiatric disorders. CNS spectrums 21(3):230–238CrossRef
6.
Zurück zum Zitat Arciniegas DB, Anderson CA (2002) Suicide in neurologic illness. Curr Treatment Options Neurol 4(6):457–468CrossRef Arciniegas DB, Anderson CA (2002) Suicide in neurologic illness. Curr Treatment Options Neurol 4(6):457–468CrossRef
7.
Zurück zum Zitat Huntington G (1872) On chorea. Med Surg Rep Weekly J 26(15):317–21 Huntington G (1872) On chorea. Med Surg Rep Weekly J 26(15):317–21
8.
Zurück zum Zitat Rodrigues FB, Abreu D, Damásio J et al (2017) Survival, mortality, causes and places of death in a European Huntington’s disease prospective cohort. Movement Disorders Clinical Practice. Rodrigues FB, Abreu D, Damásio J et al (2017) Survival, mortality, causes and places of death in a European Huntington’s disease prospective cohort. Movement Disorders Clinical Practice.
9.
Zurück zum Zitat Paulsen JS, Nehl C, Hoth KF et al (2005) Depression and stages of Huntington’s disease. J Neuropsychiatry Clin Neurosci 17(4):496–502CrossRef Paulsen JS, Nehl C, Hoth KF et al (2005) Depression and stages of Huntington’s disease. J Neuropsychiatry Clin Neurosci 17(4):496–502CrossRef
11.
Zurück zum Zitat Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (1993) Suicide risk in Huntington’s disease. J Med Genet 30(4):293–295CrossRef Di Maio L, Squitieri F, Napolitano G, Campanella G, Trofatter JA, Conneally PM (1993) Suicide risk in Huntington’s disease. J Med Genet 30(4):293–295CrossRef
13.
Zurück zum Zitat Nance M, Paulsen JS, Rosenblatt A, Wheelock V (2011) A physician’s guide to the management of Huntington’s disease. Huntington’s Disease Society of America, New York Nance M, Paulsen JS, Rosenblatt A, Wheelock V (2011) A physician’s guide to the management of Huntington’s disease. Huntington’s Disease Society of America, New York
14.
Zurück zum Zitat van Duijn E, Kingma E, van der Mast R (2007) Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiatry Clin Neurosci 19(4):441–448CrossRef van Duijn E, Kingma E, van der Mast R (2007) Psychopathology in verified Huntington’s disease gene carriers. J Neuropsychiatry Clin Neurosci 19(4):441–448CrossRef
15.
Zurück zum Zitat Epping EA, Paulsen JS (2011) Depression in the early stages of Huntington disease. Neurodegener Dis Manag 5(1):407–414CrossRef Epping EA, Paulsen JS (2011) Depression in the early stages of Huntington disease. Neurodegener Dis Manag 5(1):407–414CrossRef
16.
Zurück zum Zitat Orth M (2011) Observing Huntington’s disease: the European Huntington’s Disease Network’s REGISTRY. J Neurol Neurosurg Psychiatry 82(12):1409–1412CrossRef Orth M (2011) Observing Huntington’s disease: the European Huntington’s Disease Network’s REGISTRY. J Neurol Neurosurg Psychiatry 82(12):1409–1412CrossRef
17.
Zurück zum Zitat Dorsey ER, Investigators HSGC (2012) Characterization of a large group of individuals with Huntington disease and their relatives enrolled in the COHORT study. PloS one 7(2):e29522CrossRef Dorsey ER, Investigators HSGC (2012) Characterization of a large group of individuals with Huntington disease and their relatives enrolled in the COHORT study. PloS one 7(2):e29522CrossRef
18.
Zurück zum Zitat Kieburtz K, Penney JB, Corno P et al (2001) Unified Huntington’s disease rating scale: reliability and consistency. Neurology 11(2):136–142 Kieburtz K, Penney JB, Corno P et al (2001) Unified Huntington’s disease rating scale: reliability and consistency. Neurology 11(2):136–142
19.
Zurück zum Zitat Langbehn DR, Hayden MR, Paulsen JS (2010) CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet Part B Neuropsychiatr Genet 153(2):397–408CrossRef Langbehn DR, Hayden MR, Paulsen JS (2010) CAG-repeat length and the age of onset in Huntington disease (HD): a review and validation study of statistical approaches. Am J Med Genet Part B Neuropsychiatr Genet 153(2):397–408CrossRef
20.
Zurück zum Zitat Craufurd D, Thompson JC, Snowden JS (2001) Behavioral changes in Huntington disease. Cogn Behav Neurol 14(4):219–226 Craufurd D, Thompson JC, Snowden JS (2001) Behavioral changes in Huntington disease. Cogn Behav Neurol 14(4):219–226
21.
Zurück zum Zitat Penney JB, Vonsattel JP, Macdonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington’s disease. Ann Neurol 41(5):689–692CrossRef Penney JB, Vonsattel JP, Macdonald ME, Gusella JF, Myers RH (1997) CAG repeat number governs the development rate of pathology in Huntington’s disease. Ann Neurol 41(5):689–692CrossRef
22.
Zurück zum Zitat Beck AT, Steer RA, Brown GK (1996) Beck depression inventory-II. San Antonio 78(2):490–498 Beck AT, Steer RA, Brown GK (1996) Beck depression inventory-II. San Antonio 78(2):490–498
23.
Zurück zum Zitat Posner K, Brent D, Lucas C et al (2008) Columbia-suicide severity rating scale (C-SSRS). Columbia University Medical Center, New York Posner K, Brent D, Lucas C et al (2008) Columbia-suicide severity rating scale (C-SSRS). Columbia University Medical Center, New York
24.
Zurück zum Zitat van Duijn E, Vrijmoeth EM, Giltay EJ, Landwehrmeyer GB, Network RiotEHsD (2017) Suicidal ideation and suicidal behavior according to the C-SSRS in a European cohort of Huntington’s disease gene expansion carriers. J Affect Disord 228:194–204CrossRef van Duijn E, Vrijmoeth EM, Giltay EJ, Landwehrmeyer GB, Network RiotEHsD (2017) Suicidal ideation and suicidal behavior according to the C-SSRS in a European cohort of Huntington’s disease gene expansion carriers. J Affect Disord 228:194–204CrossRef
25.
Zurück zum Zitat Paulsen JS, Hoth KF, Nehl C, Stierman L (2005) Critical periods of suicide risk in Huntington’s disease. Am J Psychiatry 162(4):725–731CrossRef Paulsen JS, Hoth KF, Nehl C, Stierman L (2005) Critical periods of suicide risk in Huntington’s disease. Am J Psychiatry 162(4):725–731CrossRef
27.
Zurück zum Zitat Anderson KE, Eberly S, Groves M et al (2016) Risk factors for suicidal ideation in people at risk for Huntington’s disease. J Huntingt Dis 5(4):389–394CrossRef Anderson KE, Eberly S, Groves M et al (2016) Risk factors for suicidal ideation in people at risk for Huntington’s disease. J Huntingt Dis 5(4):389–394CrossRef
30.
Zurück zum Zitat Coustasse A, Pekar A, Sikula A, Lurie S (2009) Ethical considerations of genetic presymptomatic testing for Huntington’s disease. J Hosp Market Pub Relat 19(2):129–141CrossRef Coustasse A, Pekar A, Sikula A, Lurie S (2009) Ethical considerations of genetic presymptomatic testing for Huntington’s disease. J Hosp Market Pub Relat 19(2):129–141CrossRef
31.
Zurück zum Zitat Oquendo MA, Bernanke JA (2017) Suicide risk assessment: tools and challenges. World Psychiatry 16(1):28–29CrossRef Oquendo MA, Bernanke JA (2017) Suicide risk assessment: tools and challenges. World Psychiatry 16(1):28–29CrossRef
32.
Zurück zum Zitat Silverman MM, Berman AL (2014) Suicide risk assessment and risk formulation part I: a focus on suicide ideation in assessing suicide risk. Suicide Life-Threat Behav 44(4):420–431CrossRef Silverman MM, Berman AL (2014) Suicide risk assessment and risk formulation part I: a focus on suicide ideation in assessing suicide risk. Suicide Life-Threat Behav 44(4):420–431CrossRef
33.
Zurück zum Zitat Schmitz WM, Allen MH, Feldman BN et al (2012) Preventing suicide through improved training in suicide risk assessment and care: an American Association of Suicidology Task Force report addressing serious gaps in US mental health training. Suicide Life-Threat Behav 42(3):292–304CrossRef Schmitz WM, Allen MH, Feldman BN et al (2012) Preventing suicide through improved training in suicide risk assessment and care: an American Association of Suicidology Task Force report addressing serious gaps in US mental health training. Suicide Life-Threat Behav 42(3):292–304CrossRef
35.
Zurück zum Zitat van Heeringen K, Mann JJ (2014) The neurobiology of suicide. The Lancet Psychiatry 1(1):63–72CrossRef van Heeringen K, Mann JJ (2014) The neurobiology of suicide. The Lancet Psychiatry 1(1):63–72CrossRef
37.
Zurück zum Zitat Madsen T, Erlangsen A, Nordentoft M (2017) Risk estimates and risk factors related to psychiatric inpatient suicide—an overview. Int J Environ Res Pub Health 14(3):253CrossRef Madsen T, Erlangsen A, Nordentoft M (2017) Risk estimates and risk factors related to psychiatric inpatient suicide—an overview. Int J Environ Res Pub Health 14(3):253CrossRef
38.
Zurück zum Zitat Rossetti MC, Tosone A, Stratta P et al (2017) Different roles of resilience in depressive patients with history of suicide attempt and no history of suicide attempt. Revista Brasileira de Psiquiatria 39(3):216–219CrossRef Rossetti MC, Tosone A, Stratta P et al (2017) Different roles of resilience in depressive patients with history of suicide attempt and no history of suicide attempt. Revista Brasileira de Psiquiatria 39(3):216–219CrossRef
Metadaten
Titel
Risk factors of suicidal ideation in Huntington’s disease: literature review and data from Enroll-HD
Publikationsdatum
27.08.2018
Erschienen in
Journal of Neurology / Ausgabe 11/2018
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-018-9013-6

Weitere Artikel der Ausgabe 11/2018

Journal of Neurology 11/2018 Zur Ausgabe

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.